Literature DB >> 32870141

Nightmare recurrence in patients with post-traumatic stress disorder is likely a primary feature of central sympathetic nervous activation.

Madhulika A Gupta1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32870141      PMCID： PMC8034216          DOI： 10.5664/jcsm.8782

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  3 in total

1.  Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper.

Authors:  Timothy I Morgenthaler; Sanford Auerbach; Kenneth R Casey; David Kristo; Rama Maganti; Kannan Ramar; Rochelle Zak; Rebecca Kartje
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

2.  Long-term effects of treatment for chronic nightmares: is imagery rehearsal therapy robust in the COVID-19 pandemic?

Authors:  Caroline Sierro; Wendy Leslie; Benjamin Putois
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

3.  Spontaneous reporting of onset of disturbing dreams and nightmares related to early life traumatic experiences during the COVID-19 pandemic by patients with posttraumatic stress disorder in remission.

Authors:  Madhulika A Gupta
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.